James F. Holland
- PROFESSOR Hematology and Medical Oncology
- PROFESSOR Oncological Sciences
Print Profile
Specialty
Certifications
American Board of Internal Medicine
Clinical Focus
Education
MD, Columbia University
Residency, Internal Medicine
Columbia-Presbyterian Medical CenterResidency, Internal Medicine
Columbia-Presbyterian Medical CenterFellowship, Internal Medicine
Francis Delafield Hospital
Biography
Dr. Holland is the Distinguished Professor of Neoplastic Diseases.
Publications
Wang Y, Holland JJ, Bleiweiss IJ, Melana SM, Liu X, Pelisson I, Cantarella A, Stellrecht K, Mani S, Pogo BG. Detection of mammary tumor virus env gene-like sequences in human breast cancer.. Cancer Res 1995; 55(22): 5173-5179.
Pogo BG, Holland JF. Possibilities of a viral etiology for human breast cancer. A review.. Biol Trace Elem Res Review 1997; 56(1): 131-142.
Melana SM, Holland JF, Pogo BG. Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals.. Clin Cancer Res 2001; 7(2): 283-284.
Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF, Pogo BG. Identification of a proviral structure in human breast cancer.. Cancer Res 2001; 61(4): 1754-1759.
Levine PH, Pogo B, Klouj A, Coronel S, Woodson K, Melana SM, Mourali N, Holland JF. Increasing evidence for a human breast cancer virus wih geographic differences.. Cancer 2004; 101(4): 721-726.
Holland JF, Pogo B. The Biology Behind. Mouse mammary tumor virus-like infection and human breast cancer.. Cliln Cancer Res 2004 Sept; 10(17): 5647-5649.
Holland JF. Breaking the cure barrier 25 years later.. J Clin Onc 2008; 26(10): 1575.
Pogo B, Holland JF, Levine PH. Human mammary tumor virus in inflammatory breast cancer.. Cancer 2010; 116: 2741-2744.
Industry Relationships
Physicians and scientists on the faculty of Mount Sinai School of Medicine often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Holland did not report having any of the following types of financial relationships with industry during 2011 and/or 2012: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://www.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
17 East 102 Street Floor 5 West Room D5-131
New York, NY 10029
Fax: 212-860-7186
1190 Fifth Avenue
Ruttenberg Treatment Center
New York, NY 10029
